Open Now
Contact Information
21 West Clarke Avenue Suite 4001, Milford, Delaware 19963, United States
Detailed Information
Banyan Delaware
-
Services:
- Male
- Female
- In-network prescribing entity
- Private for-profit organization
- Social skills development
- Mental health services
- Case management service
- Transportation assistance
- Integrated primary care services
- Domestic violence services, including family or partner
- Suicide prevention services
- Medicaid
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Motivational interviewing
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Cognitive behavioral therapy
- Brief intervention
- Anger management
- Substance use disorder counseling
- Relapse prevention
- 12-step facilitation
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine detoxification
- Prescribes buprenorphine
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Outpatient
- Outpatient day treatment or partial hospitalization
- Intensive outpatient treatment
- Short-term residential
- Long-term residential
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Hospital inpatient detoxification
- Outpatient detoxification
- Residential/24-hour residential
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient treatment
- Residential detoxification
- Detoxification
- Substance use treatment
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Group counseling
- Individual counseling
- Family counseling
- Substance use disorder education
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
- Adults
- Young Adults
- Screening for substance use
- Comprehensive mental health assessment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for tobacco use
- Screening for mental disorders
- Smoking permitted in designated area
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Alcohol Detoxification
- Opioids detoxification
- Medication for mental disorders
- Naltrexone (oral)
- Medications for pre-exposure to prophylaxis
- Buprenorphine without naloxone
- Medications for Hepatitis C treatment
- Acamprosate (Campral®)
- Medications for HIV treatment
- Naltrexone (extended-release, injectable)
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Clonidine
- In-network prescribing entity
- Naloxone and overdose education
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- The Joint Commission
- Drug Enforcement Agency (DEA)
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State department of health
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Self-help groups
- Housing services
- Assistance with obtaining social services
- Employment counseling or training
- Mentoring/peer support
- Treatment for other addiction disorder
- Pregnant/postpartum women
- Clients with HIV or AIDS
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Active duty military
- Seniors or older adults
- Clients who have experienced sexual abuse
- Clients with co-occurring pain and substance use disorders
- Adult women
- Clients who have experienced intimate partner violence, domestic violence
- Clients with co-occurring mental and substance use disorders
- Adult men
- Clients who have experienced trauma
- Young adults
- Members of military families
- Veterans
- Vaping permitted in designated area
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- STD testing
- TB screening
- Breathalyzer or blood alcohol testing
- HIV testing
Gender Accepted
External Opioid Medications Source
Facility Operation (e.g., Private, Public)
Ancillary Services
Payment/Insurance/Funding Accepted
Treatment Approaches
Type of Opioid Treatment
Type of Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Care
Education and Counseling Services
Age Groups Accepted
Assessment/Pre-treatment
Facility Smoking Policy
Detoxification (medical withdrawal) Services
Pharmacotherapies
External Source of Medications Used for Alcohol Use Disorder Treatment
Transitional Services
License/Certification/Accreditation
Opioid Medications used in Treatment
Recovery Support Services
Other Services
Special Programs/Groups Offered
Facility Vaping Policy
Testing
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm